McMaster researcher questions injection of clot buster drugs


The prestigious British medical journal The Lancet has published a study which raises concerns about the injection of new clot buster drugs in heart attack patients.

The study by Shamir Mehta, assistant professor of medicine and
director of the coronary care unit at the McMaster University Medical
Centre, found a 25 per cent excess in bleeding into the brain in
patients administered these drugs by bolus injection.

Intracranial hemorrhage is rare but fatal or severely disabling in the
majority of cases.